Science Explorer Interactive view Map
Topic · Genetics

Vascular Anomalies and Treatments

Vascular Anomalies and Treatments is a research topic within Genetics. Science Explorer counts 15k research works in it since 1950. 8.4% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the diagnosis and management of hereditary hemorrhagic telangiectasia (HHT), a genetic disorder characterized by vascular malformations. It covers topics such as genetics, pulmonary arteriovenous malformations, embolization, epistaxis, liver involvement, SMAD4 mutations, and vascular anomalies.

  • Hereditary Hemorrhagic Telangiectasia
  • Diagnosis
  • Management
  • Genetics
  • Pulmonary Arteriovenous Malformations
  • Embolization
  • Epistaxis
  • Liver Involvement
  • SMAD4 Mutations
  • Vascular Anomalies
Research works
15k
fractional, since 1950
In the world top 10%
1.3k
per year above
Top-10% rate
8.4%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+25%
the tick is no change

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Vascular Anomalies and Treatments research?

By volume, the United States and China publish the most (703 and 387 works in 2022–2025).

By volume, 2022–2025

  1. 1 United States 703 works
  2. 2 China 387 works
  3. 3 Japan 237 works
  4. 4 India 197 works
  5. 5 United Kingdom 109 works
  6. 6 France 102 works
  7. 7 Germany 101 works
  8. 8 Italy 78 works
  9. 9 Türkiye 74 works
  10. 10 Spain 68 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 34.2%China: 18.8%Japan: 11.5%India: 9.6%6 others listed: 25.9%34%largest
United States703 · 34.2%China387 · 18.8%Japan237 · 11.5%India197 · 9.6%6 others listed533 · 25.9%

Shares of the rows listed above, not of the whole node.

Which institutions lead Vascular Anomalies and Treatments research?

By volume in 2022–2025, All India Institute of Medical Sciences publishes the most Vascular Anomalies and Treatments research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and Massachusetts General Hospital.

By volume, 2022–2025

  1. 1 All India Institute of Medical SciencesIndia 14 works
  2. 2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 13 works
  3. 3 Massachusetts General HospitalUnited States 11 works
  4. 4 Capital Medical UniversityChina 10 works
  5. 5 Mayo Clinic in ArizonaUnited States 10 works
  6. 6 Harvard UniversityUnited States 9 works
  7. 7 Sichuan UniversityChina 9 works
  8. 8 University of California, San FranciscoUnited States 8 works
  9. 9 Boston Children's HospitalUnited States 8 works
  10. 10 University of North Carolina at Chapel HillUnited States 8 works

Where is Vascular Anomalies and Treatments research done?

The largest centres of Vascular Anomalies and Treatments research in 2022–2025 are Beijing (China), Tokyo (Japan), Paris (France) and Shanghai (China).

Largest cities, 2022–2025

  1. 1 Beijing China 66 works
  2. 2 Tokyo Japan 44 works
  3. 3 Paris France 41 works
  4. 4 Shanghai China 36 works
  5. 5 London United Kingdom 34 works
  6. 6 New Delhi India 30 works
  7. 7 Boston United States 29 works
  8. 8 Seoul South Korea 27 works
  9. 9 New York United States 24 works
  10. 10 Philadelphia United States 23 works
See Vascular Anomalies and Treatments on the map

Where is the best place to study Vascular Anomalies and Treatments?

Among universities, judged by research, Chinese Academy of Medical Sciences & Peking Union Medical College, Harvard University and All India Institute of Medical Sciences score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%mean 9.03333%fractional works in this node (log) →share in the world top 10% →Chinese Academy of Medical Sciences & Peking Union Medical College: 12, 12.9%Harvard University: 9, 18.4%All India Institute of Medical Sciences: 14, 6.0%Capital Medical University: 10, 10.7%University of North Carolina at Chapel Hill: 8, 13.7%Sichuan University: 9, 7.3%University of California, San Francisco: 8, 6.2%Post Graduate Institute of Medical Education and Research: 8, 2.0%University of Florida: 8, 4.1%Harvard UniversityChinese Academy of M…Capital Medical Univ…All India Institute …
above the meannear itbelow it

One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 54.512.9%4.8×12 +63.1%
2 Harvard UniversityUnited States 49.718.4%2.8×9 +15.0%
3 All India Institute of Medical SciencesIndia 49.56.0%8.4×14 +21.8%
4 Capital Medical UniversityChina 43.610.7%6.5×10 +30.4%
5 University of North Carolina at Chapel HillUnited States 33.513.7%1.8×8 +96.2%
6 Sichuan UniversityChina 30.67.3%1.9×9 +125.9%
7 University of California, San FranciscoUnited States 28.06.2%4.9×8 +35.0%
8 Post Graduate Institute of Medical Education and ResearchIndia 26.82.0%9.1×8 +41.3%
9 University of FloridaUnited States 17.74.1%2.9×8 +55.3%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Vascular Anomalies and Treatments research growing?

Output in 2018–2022 was 25% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Vascular Anomalies and Treatments.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.